Anbio Biotechnology Class A Ordinary Shares (NNNN) Dividend History

Anbio Biotechnology is a biopharmaceutical company focused on the development and commercialization of innovative therapies, particularly in the fields of cancer treatment and immune modulation. The company emphasizes research and development to bring novel drugs to market, aiming to address unmet medical needs.

Dividend History

Anbio Biotechnology Class A Ordinary Shares currently does not pay dividends

Company News

Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System

Anbio Biotechnology launched a Chikungunya IgM/IgG Rapid Test and an AP-100 Ultra-Fast PCR system to support rapid diagnostic testing for infectious diseases, enabling quick detection of pathogens in both centralized and decentralized healthcare settings.

GlobeNewswire Inc.

Page data last updated 08/19/2025 16:49:06 UTC